
Forward Pharma: promising net-net with a tax riskForward Pharma A/S (symbol FWP in the US) used to get revenue from a royalty agreement on dimethyl fumarate. It lost patent opposition actions and entered a legal settlement. It is using settlement proceeds to fund the last lawsuit, related to a European patent. If all litigation…